General Information


DRAVP ID  DRAVPe00072

Peptide Name   4321’-1( derived from the RNase H domain of HIV-1 RT (15-mer))

Sequence  NQIIEQLIKKEKVY

Sequence Length  14

UniProt ID  No entry found

Source  Synthetic construct(derived from HIV-1 Reverse Transcriptase)



Activity Information


Target Organism  HIV

Assay  Dot-blot assay

Activity 

  • [Ref.15790559]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50>240 µM);inhibition of strand transfer catalyzed by integrase(IC50>240 µM);inhibition of disintegration catalyzed by integrase(IC50>120 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  Integrase

Mechanism  Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00072

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C80H136N20O23

Absent amino acids  ACDFGHMPRSTW

Common amino acids  IK

Mass  1746.08

Pl  8.43

Basic residues  3

Acidic residues  2

Hydrophobic residues  5

Net charge  1

Boman Index  -2441

Hydrophobicity  -64.29

Aliphatic Index  132.14

Half Life 

  •     Mammalian:1.4 hour
  •     Yeast:3 min
  •     E.coli:>10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  114.62

Polar residues  2



Literature Information


Literature 1

Title   Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.

Pubmed ID   15790559

Reference   J Biol Chem. 2005 Jun 10;280(23):21987-96.

Author   Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.

DOI   10.1074/jbc.M414679200